IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NRX Pharmaceuticals Inc (NRXP)

CUSIP: 629444209 | NYSE | Healthcare · Biotechnology | Micro Cap | 71 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Commonwealth Equity Services, LLC590,768
0.0% of portfolio›$1.7M
Prime Capital Investment Advisors, LLC124,631
0.0% of portfolio›$363.9K
Chicago Partners Investment Group LLC47,542
0.0% of portfolio›$118.4K
SBI Securities Co., Ltd.20,001
0.0% of portfolio›$58.4K
Truist Financial Corp20,000
0.0% of portfolio›$58.4K
Sjbenen Advisory, LLC15,000
0.0% of portfolio›$42.0K
Security National Bank4,200
0.0% of portfolio›$12.3K
Larson Financial Group LLC22
0.0% of portfolio›$64
StyleTurnoverLocationFiled
Commonwealth Equity Services, LLC
590,768$1.7M0.0%ETFLowWaltham, MA2026-11-02
Prime Capital Investment Advisors, LLC
124,631$363.9K0.0%ETFLowOverland Park, KS2026-10-20
Chicago Partners Investment Group LLC
47,542$118.4K0.0%GARPLowChicago, IL2026-10-27
SBI Securities Co., Ltd.
20,001$58.4K0.0%Agg GrowthLowTokyo, Mexico2026-10-22
Truist Financial Corp
20,000$58.4K0.0%CoreLowCharlotte, NC2026-10-30
Sjbenen Advisory, LLC
15,000$42.0K0.0%ETFLowChapel Hill, NC2026-10-19
Security National Bank
4,200$12.3K0.0%GrowthLowOmaha, NE2026-10-26
Larson Financial Group LLC
22$640.0%GrowthLowSt Louis, MO2026-11-05